Skip to main content

Table 3 Baseline characteristics of patients with progression of native coronary artery at 5-year follow-up

From: Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery

Characteristics Progression
(n= 286)
Nonprogression
(109)
p
Demographic profile    
Age, y 60 ± 9 60 ± 10 0.147
Female (%) 28 35 0.191
Medical history (%)    
Current Smoker 28 32 0.268
Hypertension 59 56 0.635
Myocardial infarction(yes/no) 68/77 32/23 0.052
Diabetes 34 37 0.615
CCS class I or III angina 86 90 0.297
Laboratory values, mmol/L    
Total cholesterol 222 ± 46 221 ± 46 0.964
LDL cholesterol 149 ± 39 147 ± 39 0.658
HDL cholesterol 37 ±10 38 ±10 0.078
Triglycerides 188 ± 115 190 ± 114 0.395
Medications    
   Beta-blockers 74 78 0.247
   Calcium channel antagonists 62 42 0.020
   Long-acting nitrates 86 83 0.414
   ACE inhibitors 31 34 0.564
   HMG-CoA reductase inhibitors 20 15 0.335
   Aspirin 94 96 0.331
Entry angiographic features    
Double-vessel disease, % 49 39 0.072
Triple-vessel disease, % 51 61  
Collateral circulation 38 53 0.011
Treatment Received, %    
PCI 45 23  
CABG 23 47 < 0.001
MT 32 30  
Total Events (yes, no) 76/71 24/29 0.397
New CABG, % 7 11 0.168
New PCI, % 13 9 0.252
AMI 8 5 0.252
Angina 5 years, (yes, no) 42 30 0.024
  1. Abbreviations as in table 1